Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 19,433Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Dr. Reddy's Laboratories

02 1Supriya Lifescience

03 1Naprod Life Sciences

04 2AFT Pharmaceuticals

05 1Accord healthcare

06 1Apotex Inc

07 1Aspiro Pharma

08 1Aurobindo Pharma Limited

09 1Baxter Healthcare Corporation

10 2Biological E

11 1Chia Tai Tianqing Pharmaceutical Group

12 1Cipla Medpro South Africa

13 1Etico Lifesciences

14 1Fresenius Kabi USA

15 1GENEYORK PHARMS

16 1Grupo Azevedos

17 1Juno Pharma SA (Pty) Ltd

18 1Lupin Ltd

19 1MERCK CANADA INC

20 2MSD INTL GMBH

21 1MSN Laboratories

22 2Medsurge Healthcare

23 8Merck & Co

24 1Navinta

25 1Piramal Enterprises Limited

26 1Polifarma

27 1Praxgen

28 1Qilu Pharmaceutical

29 2Reach Pharmaceuticals

30 1Sagent Pharmaceuticals

31 1Sakar Healthcare

32 1Sandoz B2B

33 1Steriscience

34 1Tecnimede

35 1Teva Pharmaceutical Industries

36 1TherDose Pharma

37 2Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-12-09

Application Number : 211160

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Regulatory Info :

Registration Country : India

Fosaprepitant

Brand Name :

Dosage Form : Injection

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Regulatory Info :

Registration Country : India

Fosaprepitant Dimeglumine

Brand Name :

Dosage Form : Lyophilised Injection

Dosage Strength : 150MG/Vial

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Naprod Life Sciences

04

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-08-26

Application Number : 204025

Regulatory Info : DISCN

Registration Country : USA

blank

05

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 205020

Regulatory Info : DISCN

Registration Country : USA

blank

06

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2021-01-12

Application Number : 210625

Regulatory Info : RX

Registration Country : USA

blank

07

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 211860

Regulatory Info : RX

Registration Country : USA

blank

08

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 212309

Regulatory Info : RX

Registration Country : USA

blank

09

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2021-03-03

Application Number : 212143

Regulatory Info : RX

Registration Country : USA

blank

10

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2016-06-09

Application Number : 206197

Regulatory Info : RX

Registration Country : USA

blank

11

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 210689

Regulatory Info : RX

Registration Country : USA

blank

12

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : EMEND

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-25

Application Number : 22023

Regulatory Info : DISCN

Registration Country : USA

blank

13

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : EMEND

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2010-11-12

Application Number : 22023

Regulatory Info : RX

Registration Country : USA

blank

14

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 209965

Regulatory Info : RX

Registration Country : USA

blank

15

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : UNKNOWN

Dosage Strength : UNKNOWN

Packaging :

Approval Date :

Application Number : 204845

Regulatory Info :

Registration Country : USA

blank

16

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2020-12-08

Application Number : 203939

Regulatory Info : DISCN

Registration Country : USA

blank

17

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 210064

Regulatory Info : RX

Registration Country : USA

blank

18

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 115MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 204015

Regulatory Info : DISCN

Registration Country : USA

blank

19

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 204015

Regulatory Info : RX

Registration Country : USA

blank

20

GENEYORK PHARMS

Country
Iran Expo
Not Confirmed
arrow

GENEYORK PHARMS

Country
arrow
Iran Expo
Not Confirmed

FOSAPREPITANT DIMEGLUMINE

Brand Name : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/VIAL

Packaging :

Approval Date : 2019-09-05

Application Number : 211624

Regulatory Info : DISCN

Registration Country : USA

blank